Novavax Inc. buy Amped
Start price
01.02.22
/
0%
€87.29
Target price
01.02.23
-
Performance (%)
-88.23%
End price
02.02.23
€10.27
Summary
This prediction ended on 02.02.23 with a price of €10.27. Massive losses of -88.23% were the result for the BUY prediction by Amped. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | -8.867% | -8.867% | 43.604% |
| iShares Core DAX® | 1.665% | 1.692% | 18.093% |
| iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
| iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
| iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to Amped what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Standard Investments for future growth
Capable Management
Innovative
Medium risks for its business
Known brand
Very Future proof/growth oriented business model
Cons
Dependend from some customers or products
Sustainability is little important
Below average Marketposition
Comments by Amped for this prediction
In the thread Novavax Inc. diskutieren
Buy Novavax Inc.
In the thread Trading Novavax Inc.
Die von Amped gewählte maximale Laufzeit wurde überschritten